EUROFINS TESTING FOR LIFE
LIVE

Serial Number

79228165

Owner

Eurofins Scientific (Ireland) Limited

Attorney

Joseph Sofer

Filing Date

Sep 18, 2017

Add to watchlist:

No watchlists yet
View on USPTO

EUROFINS TESTING FOR LIFE Trademark

Serial Number: 79228165 • Registration: 5619718

EUROFINS TESTING FOR LIFE is a trademark filed by Eurofins Scientific (Ireland) Limited on September 18, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Eurofins Scientific (Ireland) Limited

Clogherane,
Dungarvan , IE

Entity Type: 11

Trademark Details

Filing Date

September 18, 2017

Registration Date

December 4, 2018

Published for Opposition

September 18, 2018

Goods & Services

[ Apparatus for diagnosis, measurement and analysis, not for medical use, namely, spectroscopy instruments, namely readers for ELISA, namely, microplate readers, test strip readers and tube readers; laboratory equipment, namely, photometers; software for establishment, systematization, evaluation and/or collection of analytical or diagnostic data ]

Diagnostic preparations for medical and veterinary use; chemical analysis reagents for medical and veterinary use; biological reagents for medical and veterinary use; diagnostic reagents for medical and veterinary use; chemical reagents for medical and veterinary use; oligonucleotides for medical and veterinary use; polynucleotides and synthetic genes for medical and veterinary use; genetic engineering chemicals, namely, genes, gene fragments and combinations thereof for medical purposes

Research and development in the fields of animal and plant biology, physical chemistry and microbiology; research services, namely, performing physical, chemical, physical-chemical, biochemical, biological or microbiological analyses in the fields of plant and animal products; research services, namely, carrying out physical, chemical, physical chemical, biochemical, biological or microbiological analyses in the food, chemical, pharmaceutical, cosmetic and environmental industries; research services, namely, performing genetic analyses in the fields of plant and animal products; research services, namely, carrying out genetic analyses in the food, chemical, pharmaceutical, cosmetic and environmental industries; research services, namely, nuclear magnetic resonance analyses in the food, chemical, pharmaceutical, cosmetic and environmental industries; development of new technology for others, namely, method development services, namely, establishing and maintaining chemical, biological and biomolecular testing methods; conducting scientific project feasibility studies; professional consulting in the field of scientific research

Chemical preparations for scientific purposes not for medical use; diagnostic preparations for scientific use; molecular tools, namely, reagents such as probes, reaction primers and test fractions for analysis and diagnosis, all for scientific use; molecular preparations, namely, biochemical reagents, namely, probes, reaction primers and test fractions for analysis and diagnosis, all for scientific use; analytical and diagnostic testing preparations for scientific and research use, including reagents and buffers; chemical compounds for scientific use and in the field of research and not for medical use, in particular, oligonucleotides, polynucleotides, synthetic genes; oligonucleotide sequences for DNA micro-arrays for scientific purposes; genetic engineering chemicals, namely genes, gene fragments and combinations thereof for scientific purposes

Personnel placement services, namely, provision of specialized personnel for scientific analysis in the fields of research and development, in the fields of chemical analysis, physical chemistry, biochemistry, molecular biology, virology, cellular biology and microbiology

Medical services, namely, blood testing, saliva and body fluid testing; medical services, namely, serological and urinary testing services; medical testing services in the field of genetics, namely birth defects and prenatal testing; DNA screening for medical purposes; medical and health services related to DNA, namely genetic testing for medical uses; hospital services; medical services and medical services in the field of genetics; medical clinic services; medical consultancy services; genetic consultation; medical equipment rental; maintaining personal medical history records and files online; human fertility treatment services; hygiene and beauty care for human beings and animals; collection and preservation of human blood; medical testing for diagnostic purposes; information relating to cardiovascular health and cardiovascular health analysis; medical services, namely, a program to improve health and quality of life in the field of cardiovascular diseases, namely, medical monitoring and reporting in the field of cardiovascular diseases; medical diagnostic tests in the field of diabetes

Filing History

GENERIC MADRID TRANSACTION SENT TO IB
Jul 19, 2026 XXSS
GENERIC MADRID TRANSACTION CREATED
Jul 19, 2026 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 23, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Apr 23, 2025 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Apr 23, 2025 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 20, 2025 APRE
TEAS SECTION 71 & 15 RECEIVED
Dec 3, 2024 ES75
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 29, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 13, 2019 FICS
FINAL DISPOSITION PROCESSED
Mar 13, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 4, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 4, 2018 R.PR
PUBLISHED FOR OPPOSITION
Sep 18, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Sep 15, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 29, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 29, 2018 OP2R
NOTICE OF PUBLICATION
Aug 29, 2018 NPUB
ASSIGNED TO LIE
Aug 16, 2018 ALIE
EXAMINERS AMENDMENT MAILED
Aug 7, 2018 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 6, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 6, 2018 XAEC
EXAMINERS AMENDMENT -WRITTEN
Aug 6, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 18, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 17, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 17, 2018 TROA
REFUSAL PROCESSED BY IB
Apr 13, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 23, 2018 RFCS
REFUSAL PROCESSED BY MPU
Mar 23, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 16, 2018 RFCR
NON-FINAL ACTION WRITTEN
Mar 15, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 13, 2018 MAFR
ASSIGNED TO EXAMINER
Mar 9, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 9, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 8, 2018 REPR